Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuru Fukui

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Prenatal Diagnosis|November 8, 2014
Characteristic differences and reference ranges for mitral, tricuspid, aortic, and pulmonary Doppler velocity waveforms during fetal lifeYasushi Kurihara, Daisuke Tachibana, Sakika Yanai, et al.
Anticancer Research|April 25, 2023
Influence of Smoking History on the Effectiveness of Immune-checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer: Analysis of Real-world DataKenji Nakahama, Motohiro Izumi, Naoki Yoshimoto, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2023
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancerKenji Nakahama, Motohiro Izumi, Naoki Yoshimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2019
Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsYoshiya Matsumoto, Kenji Sawa, Mitsuru Fukui, et al.
Cancer Science|August 2, 2019
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancerYoshiya Matsumoto, Kenji Sawa, Mitsuru Fukui, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2007
Dietary fiber and risk of colorectal cancer in the Japan collaborative cohort studyKenji Wakai, Chigusa Date, Mitsuru Fukui, et al.
Cancer Science|June 20, 2022
Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non-small cell lung cancerKenji Nakahama, Hiroyasu Kaneda, Masahiko Osawa, et al.
Scientific Reports|March 12, 2021
Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factorsMotohiro Izumi, Jun Oyanagi, Kenji Sawa, et al.
Molecular Genetics and Metabolism|April 26, 2011
Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuriaYoshitami Sanayama, Hironori Nagasaka, Masaki Takayanagi, et al.
BMJ Open|September 10, 2020
Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in JapanKoichi Ogawa, Yasuhiro Koh, Hiroyasu Kaneda, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Prenatal Diagnosis|November 8, 2014
Characteristic differences and reference ranges for mitral, tricuspid, aortic, and pulmonary Doppler velocity waveforms during fetal lifeYasushi Kurihara, Daisuke Tachibana, Sakika Yanai, et al.
Anticancer Research|April 25, 2023
Influence of Smoking History on the Effectiveness of Immune-checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer: Analysis of Real-world DataKenji Nakahama, Motohiro Izumi, Naoki Yoshimoto, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2023
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancerKenji Nakahama, Motohiro Izumi, Naoki Yoshimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2019
Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsYoshiya Matsumoto, Kenji Sawa, Mitsuru Fukui, et al.
Cancer Science|August 2, 2019
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancerYoshiya Matsumoto, Kenji Sawa, Mitsuru Fukui, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2007
Dietary fiber and risk of colorectal cancer in the Japan collaborative cohort studyKenji Wakai, Chigusa Date, Mitsuru Fukui, et al.
Cancer Science|June 20, 2022
Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non-small cell lung cancerKenji Nakahama, Hiroyasu Kaneda, Masahiko Osawa, et al.
Scientific Reports|March 12, 2021
Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factorsMotohiro Izumi, Jun Oyanagi, Kenji Sawa, et al.
Molecular Genetics and Metabolism|April 26, 2011
Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuriaYoshitami Sanayama, Hironori Nagasaka, Masaki Takayanagi, et al.
BMJ Open|September 10, 2020
Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in JapanKoichi Ogawa, Yasuhiro Koh, Hiroyasu Kaneda, et al.
Pageof 7